New Jersey Assembly Bill A2363

New Jersey 2024-2025 Regular Session

• Introduced: 1/9/24
• Refer: 1/9/24

Caption

Requires nursing homes to submit certain cost reports to DOH in annual financial report.

Impact

The proposed amendments will modify existing laws which currently require nursing homes to file annual financial reports. By including the most recent cost reports submitted to the federal Centers for Medicare and Medicaid Services within these reports, the bill intends to provide the DOH with comprehensive data on nursing home finances. Additionally, the Commissioner of Health would be tasked with preparing and publishing an annual report that aggregates this data regionally and by county, though individual nursing homes would remain unnamed.

Summary

A2363 is a legislative bill introduced in the New Jersey Assembly that aims to enhance financial reporting requirements for nursing homes. The bill mandates that nursing homes submit specific cost reports alongside their annual financial reports to the Department of Health (DOH). This new reporting requirement seeks to ensure greater transparency in the operations and finances of nursing homes, facilitating better oversight and accountability.

Conclusion

Overall, A2363 represents an effort to increase transparency in the nursing home sector in New Jersey, with implications for state health policy and regulatory practices. Supporters of the bill are likely to argue that such measures are necessary for safeguarding the financial integrity of nursing homes and protecting residents, while opponents may see it as an unwarranted intrusion into business operations.

Contention

Notably, the bill alters the criteria for reporting ownership interests in nursing homes. Previously, only those holding 10% or greater ownership had to be reported; A2363 expands this to include any amount of ownership interest. This provision may generate concerns regarding privacy and operational confidentiality among nursing home owners and operators, which could lead to debates about the balance between regulatory oversight and business confidentiality.